XML 18 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Equity Instruments (Tables)
3 Months Ended
Sep. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Options Valuation Assumption

time of the grant for treasury securities of similar maturity. Aytu has computed the fair value of all options granted during the three months ended September 30, 2015 using the following assumptions:

 

Expected volatility

   75.00%

Risk free interest rate

   1.08% – 1.59%

Expected term (years)

   3.0 – 4.5

Dividend yield

   0%
Stock Option Activity

Stock option activity is as follows:

 

     Number of
Options
     Weighted
Average
Exercise Price
     Weighted Average
Remaining Expected
Life in Years
 

Outstanding June 30, 2015

     —         $ —        

Granted

     50,000       $ 4.63      

Exercised

     —         $ —        

Forfeited/Cancelled

     —         $ —        
  

 

 

       

Outstanding September 30, 2015

     50,000       $ 4.63         4.86   
  

 

 

       

Exercisable at September 30, 2015

     —         $ —        
  

 

 

       

Available for grant at September 30, 2015

     9,950,000         
  

 

 

       
Summary of Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense for the three months ended September 30, 2015 and for the stock-based compensation expense related to the Luoxis and Vyrix options for the three months ended September 30, 2014:

 

     Three Months Ended September 30,  
     2015      2014  

Research and development expenses

     

Stock options

   $ 5,000       $ 90,000   

Selling, general and administrative expenses

     

Stock options

     63,000         112,000   
  

 

 

    

 

 

 
   $ 68,000       $ 202,000   
  

 

 

    

 

 

 

Unrecognized expense at September 30, 2015

   $ 10,000      

Weighted average remaining years to vest

     3.55      
Warrants Issued in Conjunction with its Senior Convertible Debentures

A summary of these warrants is as follows:

 

     Number of
Warrants
     Weighted
Average
Exercise Price
     Weighted Average
Remaining Expected
Life in Years
 

Outstanding June 30, 2015

     102,613       $ 4.53         2.92   

Outstanding September 30, 2015 (unaudited)

     102,613       $ 4.53         2.92